Robert Alan Beardsley's most recent trade in Arbutus Biopharma Corp was a trade of 78,800 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 8, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arbutus Biopharma Corp | Robert Alan Beardsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2026 | 78,800 | 78,800 | - | - | Stock Option (Right to Buy) |